Australia vs Netherlands: Previously treated cases tested for RR-/MDR-TB
Australia
76.0%
in 2024
Netherlands
75.0%
in 2024
Australia rank
120th
Netherlands rank
123rd
Previously treated cases tested for RR-/MDR-TB over time
- Australia
- Netherlands
How they compare
Australia currently reports 76.0% against 75.0% in Netherlands, a difference of 1.0%.
The two have swapped places 8 times across 14 shared years of data; in 2010 it was Australia ahead.
Australia ranks 120th and Netherlands ranks 123rd of 180 countries.
Australia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Australia | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 72.0% | 67.2% | 4.8% | Australia |
| 2020s | 74.2% | 72.2% | 2.0% | Australia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Australia or Netherlands?
- Australia, at 76.0% against 75.0% in Netherlands as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Australia and Netherlands?
- 1.0%, with Australia ahead.
- How many years of comparable data are there for Australia and Netherlands?
- 14 years are reported by both, from 2010 to 2024.
- How do Australia and Netherlands rank globally for previously treated cases tested for rr-/mdr-tb?
- Australia ranks 120th and Netherlands ranks 123rd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.